General Clinical Chemistry Analyzers and Accessories
Heska Corporation COMPREHENSIVE PANEL-EWRAP 6/BX
This item has a minimum qty of 2 per supplier requirements.
Bio Rad Laboratories TRANS-BLOT TURBO TRANSFER PACK
10 mini nitrocellulose transfer pack for Trans-Blot Turbo Rapid Transfer Instrument. (170-4158)
BTNX Inc BTNX CLIA-Waived Urine Analyzer (Smart with Barcode Reader) 1 Unit
Streamline your clinic’s testing with the Rapid Response™ U121S Urine Analyzer – an efficient and accurate tool for interpreting Rapid Response™ Urinalysis Reagent Strips results. With the ability to swiftly read, store, and print results in under two minutes, the U121S Urine Analyzer improves workflow efficiency while reducing the chance of human error. Rapid Response™ U121S Urine Analyzer is intended to be used in conjunction with Rapid Response™ Urinalysis Reagent Strips. Together they can be used to aid in the general evaluation of health, the diagnosis and monitoring of metabolic, systemic, or endocrine disorders affecting kidney function, and detecting diseases of the urinary tract. For professional in vitro diagnostic use only. CLIA-Waived.Ideal for clinics with a high throughput, the Rapid Response™ U121S, conveniently includes a barcode reader offering quick canister code recognition and Patient ID entry.
Abcam LM22A-4, neurotrophic BDNF mimetic, 50MG
MW 339.34 Da, Purity >98%. Small molecule BDNF mimetic displaying neurotrophic activity. Partial agonist at TrkB, activating TrkB signaling. Displaces BDNF (IC₅₀ = 47 nM) in binding assays. Prevents neuronal degeneration with equal efficacy to that of BDNF in in vitro models of neurodegenerative disease. Causes hippocampal and striatal TrkB activation in mice and improved motor learning after traumatic brain injury in rats, after in vivo administraton. Improves respiratory function in a mouse model of Rett syndrome.
The product is subject to the following: Abcam Restricted Use Statement
Abcam UC2288, p21 inhibitor, 25MG
MW 481.8 Da, Purity >98%. Cell-permeable, phenylcyclohexyl-urea based compound that selectively downregulates the expression of p21, independent of p53 expression, at either transcription or post-transcriptional level. Attenuates p21 protein levels with minimal effect on p21 protein stability. Has no significant effect on the activities of Raf kinases, VEGFR2 kinase, or the phosphorylation state of ERK. Effectively inhibits the growth of multiple cancer cell lines (GI₅₀ = ~ 10 μM against NCI60 cell lines).
The product is subject to the following: Abcam Restricted Use Statement
Abcam UC2288, p21 inhibitor, 5MG
MW 481.8 Da, Purity >98%. Cell-permeable, phenylcyclohexyl-urea based compound that selectively downregulates the expression of p21, independent of p53 expression, at either transcription or post-transcriptional level. Attenuates p21 protein levels with minimal effect on p21 protein stability. Has no significant effect on the activities of Raf kinases, VEGFR2 kinase, or the phosphorylation state of ERK. Effectively inhibits the growth of multiple cancer cell lines (GI₅₀ = ~ 10 μM against NCI60 cell lines).
The product is subject to the following: Abcam Restricted Use Statement
Abcam UC2288, p21 inhibitor, 10MG
MW 481.8 Da, Purity >98%. Cell-permeable, phenylcyclohexyl-urea based compound that selectively downregulates the expression of p21, independent of p53 expression, at either transcription or post-transcriptional level. Attenuates p21 protein levels with minimal effect on p21 protein stability. Has no significant effect on the activities of Raf kinases, VEGFR2 kinase, or the phosphorylation state of ERK. Effectively inhibits the growth of multiple cancer cell lines (GI₅₀ = ~ 10 μM against NCI60 cell lines).
The product is subject to the following: Abcam Restricted Use Statement